From the Literature: Seizures


Review the key findings from three recently published studies looking at management of seizures in the hospital setting.

Epilepsia (October 2010)

Authors: Buckingham S, Chervoneva I, Sharan A, et al.

Purpose: To determine the prognostic significant of the time from surgery to first seizure relapse in predicting long-term impact in patients.

Results: Retrospective analysis of patients who reported at least one complex partial seizure or generalized tonic-clonic seizure after anterior temporal lobectomy showed that “the latency from surgery to the first postoperative disabling seizure was significantly associated with long-term outcome.” Longer latency was associated with higher odds of being seizure-free or improved relative to the unimproved state, while “shorter latency increased the likelihood of achieving the worst prognosis.”

Click here to access this third party resource.

Correlation between Serum Selenium Level and Febrile SeizuresJournal: Pediatric Neurology (November 2010)

Authors: Mahyar A, Ayazi P, Fallahi M, Javadi A.

Purpose: A case-control study was conducted in the Children’s Hospital in Qazvin, Iran, to assess the association between serum selenium level and simple febrile seizures in children

Results: A comparison of serum selenium levels in 30 children who experienced simple febrile seizures with those of febrile children without seizure showed that levels were significantly lower in those who had simple febrile seizures. Researchers concluded that there seems to be “an association between serum selenium deficiency and simple febrile seizures.” Further study, however, is recommended.

Click here to access this third party resource.

A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and GabapentinJournal: Clinical Pharmacokinectics (October 1, 2010)

Authors: Bockbrader H, Wesche D, Miller R, et al.

Purpose: To compare the pharmacokinetics of pregabalin and gabapentin, two drugs that “share a similar mechanism of action, inhibiting calcium influx and subsequent release of excitatory neurotransmitters,” yet differ in their pharmacokinetic and pharmacodynamic characteristics. “Gabapentin is absorbed slowly after oral administration, with maximum plasma concentrations attained within 3—4 hours,” while “orally administered pregabalin is absorbed more rapidly, with maximum plasma concentrations attained within 1 hour.”

Results: Both drugs show dose-response relationships in the treatment of postherpetic neuralgia and partial seizures; a pregabalin dosage of 450 mg/day appears to reduce neuropathic pain comparably to the predicted maximum effect of gabapentin, while as an antiepileptic, “pregabalin may be more effective based on the magnitude of the reduction in the seizure frequency.” Researchers concluded that “pregabalin appears to have some distinct pharmacokinetic advantages over gabapentin that may translate into an improved pharmacodynamic effect.”

Click here to access this third party resource.

Related Videos
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
Stephanie Nahas, MD, MSEd | Credit: Jefferson Health
Mikkael Sekeres, MD:
© 2024 MJH Life Sciences

All rights reserved.